Skip to main content

Table 3 Effects of SCP on body weight, liver weight and liver index in NAFLD mice (n = 10)

From: Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice

Group

Body weight (g)

Liver weight (g)

liver weight/body weight ratio

CON

29.57 ± 2.25

1.05 ± 0.18

3.52 ± 0.85

CON + SCP

28.94 ± 1.84

1.02 ± 0.14

3.47 ± 0.68

NAFLD

30.52 ± 2.34

1.37 ± 0.11*

4.58 ± 0.60*

NAFLD + SCP

28.56 ± 1.97

1.16 ± 0.19#

4.03 ± 0.71#

  1. CON: treated with saline 0.1 mL/10g; NAFLD: treated with saline 0.1 mL/10g; CON + SCP and NAFLD + SCP: treated with SCP (100 mg/kg). Data are expressed as mean ± SD (n = 10) and analyzed using one-way ANOVA with post hoc test
  2. SCP Schisandra polysaccharide, NAFLD non-alcoholic fatty liver disease, SD standard deviation, ANOVA, analysis of variance
  3. * P < 0.05 vs. CON and CON + SCP groups; # P < 0.05 vs. model group
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X